irasia.com - Investor Relations Asia Pacific
HOME

Dawnrays Pharmaceutical (Holdings) Limited

Press Releases       


Please download the latest "Acrobat Reader" to view the PDF.

  • 2011-December-20
  • Press Release (Chinese Version) (in PDF)
  • 2011-August-22
  • Dawnrays Pharmaceutical (Holdings) Limited Announced Interim Results for the Six Months Ended 30 June 2011: Net Profit after Tax Jumped 2.9% to RMB 90.06 Million, an Interim Dividend of HK$ 0.02 per Share was Declared (in PDF)
  • 2011-March-14
  • Dawnrays Pharmaceutical (Holdings) Limited Announced Annual Results for the Year Ended 31 December 2010: Net Profit after Tax Jumped 41.0% to RMB 166.84 Million, a Final Dividend of HK$ 0.078 per Share was Declared (in PDF)
  • 2011-March-14
  • Dawnrays Pharmaceutical (Holdings) Limited Levamlodipine Besylate Tablets, a Cardiovascular Therapeutic Drug and Cefprozil Tablets, an Oral Cephalosporin Antibiotic, Have Been Granted Production Approvals from the State Food and Drug Administration (in PDF)
  • 2013
  • 2013 Press Releases
  • 2012
  • 2012 Press Releases
  • 2010
  • 2010 Press Releases
  • 2009
  • 2009 Press Releases
  • 2008
  • 2008 Press Releases
  • 2006
  • 2006 Press Releases
  • 2005
  • 2005 Press Releases


  • Company's Index
  • irasia.com

  • About irasia.com   |   Terms of Use   |   Disclaimer
    © Copyright 1996-2013 irasia.com Ltd. All rights reserved.
    DISCLAIMER:
    irasia.com Ltd. makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd. be liable for damages resulting from the use of the information provided on this website.